Commit Biologics Appoints Mikkel Wandahl Pedersen as Interim CEO
PRIVATEFeb 02, 2025
Company
Commit Biologics
AarhusBiotechnologyHealth CareTherapeutics
Description
Commit Biologics announced the appointment of Mikkel Wandahl Pedersen as Interim Chief Executive Officer. Dr. Pedersen, a seasoned R&D executive with extensive experience in immuno-oncology and autoimmune disease drug discovery and development, will lead the execution of the company's plan.
Who to call at Commit Biologics, and when
A new leader at Commit Biologics brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Commit Biologics raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Commit Biologics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Commit Biologics. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Commit Biologics
Location
Aarhus, Central Denmark Region, Denmark
About
Commit Biologics is a company specializing in activating the complement system to treat cancer and autoimmune diseases using their unique Bispecific Complement Engaging (BiCE™) platform.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Commit Biologics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.